Deyab et al., in a study of RA patients treated with methotrexate (MTX) alone and patients receiving MTX plus biological agents, identified an association between the C-reactive protein (CRP) and syndecan-1 levels, suggesting a relationship between this molecule and inflammation [21]. This evidence concerns the gene SDC1 and rheumatoid arthritis.